Researchers spearhead groundbreaking research into treatment of brain swelling

May 22, 2012

Researchers at Trinity College Dublin have reported the results of groundbreaking research into the prevention of cerebral oedema or swelling of the brain, a major cause of death in people who have sustained a traumatic injury to the brain, out of hospital cardiac arrest or stroke. The research, which is published this week in the international journal, Nature Communications, uses a radically new patented technology, developed in Ireland and termed, 'Neuronal Barrier Modulation' which has been shown in an animal model simulating human brain swelling, to be highly effective in reducing the dangerous effects of this condition, while improving cognitive outcome. The research was sponsored by the US Department of Defense and Enterprise Ireland.

The researchers have devised a method of safely manipulating the blood vessels in the brain to allow for periodic opening of tight junction channels between cells lining the vessels. A simple medication can be injected into a peripheral vein, rendering the blood vessels in the brain marginally and reversibly permeable to and this procedure allows the fluid in the brain, largely comprising water, to efficiently drain back into the blood.

"Unfortunately, there has been little change in treatment of acute over the past 80 years and this is a major cause of mortality in traumatic brain injury (TBI), stroke and out-of-hospital cardiac arrest," says Senior Author of the Nature Communications paper, Dr. Matthew Campbell, of the Ocular Genetics Unit at Trinity College Dublin. "We developed the technique initially for treatment of neuronal edema in cases where injury has occurred to the , the region of the brain involved in vision, in view of our Unit's profile in vision research, however, the same method can be used in alleviating edema in all ," says Dr. Campbell.

In Europe alone, brain injuries cause over 66,000 deaths while almost 1.6 million people are admitted to hospital each year. Similar numbers are affected by stroke and cardiac arrest. In fact, more people suffer a (TBI) each year than the numbers diagnosed with breast, lung, prostate, brain, and colon cancer combined.

"The medication is based on the use of RNA Interference, a demanding technology which has had a bumpy ride within the pharmaceuticals industry in recent years, and I am delighted that a highly effective and simply deployable therapeutic strategy has emerged based on this technology. There is now a clear path to clinical deployment," says Professor Pete Humphries, Director of the Ocular Genetics Unit at Trinity College Dublin, where the work was carried out.

"Malignant brain swelling as a consequence of , head injury, stroke, and brain tumours is the single most common factor leading to death in Western society and plays a major role in worsening the outcome of those who survive. Given how common these conditions are, anything that could significantly reduce the effect of swelling is likely to have a profound impact on morbidity and mortality and will have reverberations though the public health system," continued co-author, neurologist, Dr Colin Doherty, MD, St James's Hospital, Dublin.

The technology the researchers have reported is planned to enter Phase I clinical trials both here, with neurologist Dr Colin Doherty and in the US along with the team's collaborator, neurosurgeon Professor Gerald Grant, at Duke University and will be developed by the recently established Irish Company, Avena Therapeutics Ltd. Veteran life-science investor and Executive Chairman of the Company, Jeremy L. Curnock Cook says: "This sort of thing doesn't happen too often and we have now been presented with a remarkable and exciting opportunity thanks to the Trinity researchers and their supporters both here and in the US".

Explore further: Traumatic brain injury: NIH-funded researchers will assess biomarkers for diagnosis and treatment

More information: Full title of the paper "Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury"

Related Stories

Traumatic brain injury: NIH-funded researchers will assess biomarkers for diagnosis and treatment

August 3, 2011
Biomarkers in the bloodstream could provide physicians with a quick and accurate method of assessing the severity of traumatic brain injury (TBI) and helping deliver and monitor the results of therapies, such as progesterone ...

Traumatic brain injury linked with tenfold increase in stroke risk

July 28, 2011
If you suffer traumatic brain injury, your risk of having a stroke within three months may increase tenfold, according to a new study reported in Stroke: Journal of the American Heart Association.

Skull resconstruction immediately following traumatic brain injury worsens brain damage

March 22, 2012
Immediate skull reconstruction following trauma that penetrates or creates an indentation in the skull can aggravate brain damage inflicted by the initial injury, a study by a University of South Florida research team reports. ...

Recommended for you

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

New technique overcomes genetic cause of infertility

August 17, 2017
Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

Inhibiting a protein found to reduce progression of Alzheimer's and ALS in mice

August 17, 2017
(Medical Xpress)—A team of researchers with Genetech Inc. and universities in Hamburg and San Francisco has found that inhibiting the creation of a protein leads to a reduction in the progression of Alzheimer's disease ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.